MaltSci 麦伴科研

Appearance

Popular Reports / Immunology

This report is written by MaltSci based on the latest literature and research findings

What is the role of extracellular vesicles in immune communication? ​

Abstract ​

Extracellular vesicles (EVs) have emerged as critical mediators of intercellular communication within the immune system, playing essential roles in both innate and adaptive immunity. These nanoscale membrane-bound structures, which include exosomes and microvesicles, are secreted by various cell types and carry a complex cargo of proteins, lipids, and nucleic acids. The biogenesis of EVs involves intricate cellular processes that lead to their formation from multivesicular bodies or direct budding from the plasma membrane. This review provides a comprehensive overview of the characteristics, biogenesis, and diverse cargo of EVs, emphasizing their involvement in immune communication. EVs facilitate key processes such as antigen presentation, immune cell activation, and modulation of immune tolerance, thereby influencing the immune response to pathogens and the pathogenesis of immune-related disorders. Furthermore, the therapeutic potential of EVs is explored, including their application as biomarkers and in immunotherapy and vaccination strategies. Understanding the mechanisms by which EVs influence immune communication is vital for developing novel therapeutic strategies aimed at various diseases. Future research directions and challenges in EV research are also discussed, highlighting the need for further investigation into their roles in clinical applications.

Outline ​

This report will discuss the following questions.

  • 1 Introduction
  • 2 Biogenesis and Characteristics of Extracellular Vesicles
    • 2.1 Types of Extracellular Vesicles
    • 2.2 Mechanisms of EV Biogenesis
  • 3 Cargo of Extracellular Vesicles
    • 3.1 Protein Composition
    • 3.2 Lipid and RNA Content
  • 4 Role of Extracellular Vesicles in Immune Communication
    • 4.1 EVs in Innate Immunity
    • 4.2 EVs in Adaptive Immunity
    • 4.3 EVs in Immune Regulation and Tolerance
  • 5 Therapeutic Potential of Extracellular Vesicles
    • 5.1 EVs as Biomarkers
    • 5.2 EVs in Immunotherapy and Vaccination
  • 6 Future Directions and Challenges
    • 6.1 Research Gaps
    • 6.2 Technical Challenges in EV Study
  • 7 Conclusion

1 Introduction ​

Extracellular vesicles (EVs) have garnered significant attention in recent years as pivotal mediators of intercellular communication, particularly within the immune system. These nanoscale membrane-bound structures, which include exosomes, microvesicles, and apoptotic bodies, are secreted by a diverse array of cell types and carry a complex cargo of proteins, lipids, and nucleic acids. The multifaceted roles of EVs in modulating immune responses highlight their importance not only in maintaining immune homeostasis but also in the pathogenesis of various immune-related disorders, including cancer, autoimmune diseases, and infectious diseases [1][2].

The significance of EVs in immune communication stems from their ability to facilitate communication between immune cells as well as between immune and non-immune cells. They are involved in crucial processes such as antigen presentation, immune cell activation, and the modulation of immune tolerance [2][3]. Recent studies have illustrated the dual roles of EVs in promoting both immune activation and tolerance, suggesting that they are essential players in both innate and adaptive immunity [1][4]. As such, understanding the mechanisms by which EVs influence immune communication is vital for developing novel therapeutic strategies aimed at various diseases [1].

Current research has expanded our understanding of the biogenesis, composition, and functional implications of EVs in different immune contexts. The biogenesis of EVs involves intricate cellular processes that lead to the formation of these vesicles from multivesicular bodies or through direct budding from the plasma membrane [5]. Furthermore, the cargo of EVs varies significantly depending on the cell type of origin and the physiological or pathological context, influencing their functional outcomes in recipient cells [2][6].

This review is organized to systematically explore the roles of EVs in immune communication. The first section will detail the biogenesis and characteristics of EVs, highlighting the different types of EVs and the mechanisms underlying their formation. Following this, we will examine the diverse cargo of EVs, focusing on their protein composition, lipid content, and RNA species, including microRNAs that play crucial roles in gene regulation [4][6].

The subsequent sections will delve into the specific roles of EVs in immune communication, detailing their involvement in both innate and adaptive immunity, as well as their regulatory functions in immune tolerance [1][2]. We will also discuss the therapeutic potential of EVs, including their application as biomarkers and their emerging roles in immunotherapy and vaccination strategies [4][6].

Finally, we will address future directions and challenges in EV research, identifying existing gaps in the literature and technical hurdles that must be overcome to fully harness the potential of EVs in clinical applications [1][2]. By synthesizing current knowledge and highlighting areas for further investigation, this review aims to provide a comprehensive overview of the role of extracellular vesicles in immune communication, emphasizing their significance in both health and disease.

2 Biogenesis and Characteristics of Extracellular Vesicles ​

2.1 Types of Extracellular Vesicles ​

Extracellular vesicles (EVs), which include exosomes and microvesicles, play a critical role in immune communication by mediating intercellular signaling and influencing immune responses. These small membranous structures are secreted by nearly all cell types and contain a diverse array of bioactive molecules, including proteins, lipids, and nucleic acids. The biogenesis of EVs occurs through two primary pathways: exosomes are formed within multivesicular bodies and released upon fusion with the plasma membrane, while microvesicles bud directly from the plasma membrane. This process results in vesicles that vary in size, composition, and function, allowing them to perform distinct roles in cellular communication and immune modulation [1][2][3].

The characteristics of EVs are defined by their heterogeneous nature, encompassing differences in size, lipid composition, and cargo content, which reflect the physiological state of the parent cell. For instance, EVs derived from immune cells may carry specific surface markers and functional proteins that facilitate their role in immune regulation [1][2]. These vesicles can transfer signaling molecules to recipient cells, thereby modulating their behavior, promoting activation, or inducing tolerance. The transfer of microRNAs and other genetic materials via EVs can lead to changes in gene expression in target cells, further influencing immune responses [4][6].

In the context of immune communication, EVs serve several pivotal functions. They are involved in antigen presentation, wherein they can carry major histocompatibility complex (MHC) molecules that present antigens to T cells, thus initiating adaptive immune responses [1]. Additionally, EVs can modulate the activation and differentiation of various immune cell types, including dendritic cells, macrophages, and T lymphocytes. This modulation is crucial for maintaining immune homeostasis and responding to pathogens [2][3].

Furthermore, EVs have been implicated in the pathogenesis of various immune-related disorders, including autoimmune diseases and cancer. In these contexts, they can contribute to chronic inflammation and tissue damage by delivering pro-inflammatory mediators or suppressing immune responses through the transfer of inhibitory signals [1][3]. This duality underscores the complexity of EVs as both mediators of immune communication and potential therapeutic targets.

The emerging understanding of EVs in immune communication highlights their potential as biomarkers for disease and as vehicles for targeted therapies. Research is ongoing to explore their use in diagnostics and therapeutics, particularly in the realms of cancer immunotherapy and the treatment of autoimmune diseases [4][6]. Overall, the role of extracellular vesicles in immune communication is a dynamic and multifaceted area of study, with significant implications for both basic immunology and clinical applications.

2.2 Mechanisms of EV Biogenesis ​

Extracellular vesicles (EVs) are small membranous structures secreted by nearly all cell types, playing a crucial role in intercellular communication, particularly within the immune system. They are involved in the transfer of bioactive molecules, including proteins, lipids, and nucleic acids, thereby influencing the function and behavior of recipient cells. The biogenesis of EVs involves distinct pathways, primarily classified into exosomes and microvesicles, each characterized by different mechanisms of formation.

Exosomes are formed through the inward budding of the endosomal membrane, leading to the creation of multivesicular bodies (MVBs). These MVBs can either fuse with lysosomes for degradation or with the plasma membrane to release exosomes into the extracellular space. This process is regulated by various proteins, including those from the endosomal sorting complexes required for transport (ESCRT) pathway, which facilitate the sorting of cargo into intraluminal vesicles during MVB formation[2].

Microvesicles, on the other hand, are generated by the outward budding and fission of the plasma membrane. This process is often influenced by changes in the cellular environment, such as calcium influx and cytoskeletal rearrangements. The distinct formation pathways of exosomes and microvesicles result in variations in their size, content, and functional properties[5].

The characteristics of EVs, including their lipid bilayer structure, allow them to encapsulate a diverse range of molecular cargo. This cargo can include not only proteins and lipids but also various forms of RNA, such as messenger RNA (mRNA) and microRNA (miRNA), which can be delivered to target cells, thus modulating gene expression and influencing cellular responses[1].

In the context of immune communication, EVs serve as mediators that facilitate the interaction between immune cells and other cell types. They play significant roles in immune cell activation, antigen presentation, and immunomodulation, which are essential for maintaining immune homeostasis and responding to pathogens. For instance, EVs can deliver antigens to dendritic cells, enhancing their ability to activate T cells and elicit adaptive immune responses[7]. Moreover, the content of EVs can reflect the physiological state of their parent cells, providing valuable information about the immune environment and aiding in the identification of disease states[8].

Understanding the mechanisms of EV biogenesis and their characteristics is crucial for elucidating their roles in immune communication. This knowledge can also pave the way for the development of novel therapeutic strategies, particularly in the context of immunological disorders and cancer, where EVs may serve as potential biomarkers or therapeutic agents[4].

3 Cargo of Extracellular Vesicles ​

3.1 Protein Composition ​

Extracellular vesicles (EVs), including exosomes and microvesicles, play a crucial role in immune communication by serving as vehicles for the transfer of various bioactive molecules, including proteins, lipids, and nucleic acids. These vesicles are secreted by nearly all cell types and have emerged as significant mediators of intercellular communication, particularly within the immune system.

The protein composition of extracellular vesicles is diverse and reflects the physiological state of the parent cell. EVs carry a subset of proteins that can influence the behavior of recipient cells. For instance, they are involved in immune cell activation, antigen presentation, and immunomodulation, which are vital for maintaining immune homeostasis and responding to pathogens. This protein cargo can include cytokines, chemokines, and receptors that facilitate communication between immune and non-immune cells, thereby modulating immune responses [1].

In the context of immune regulation, EVs contribute to the transfer of signaling proteins that can alter the function of target cells. For example, EVs derived from dendritic cells can present antigens to T cells, thereby enhancing the adaptive immune response. Additionally, EVs can deliver immunosuppressive factors that may inhibit excessive immune activation, highlighting their role in balancing immune responses [2].

The involvement of myeloid immune cells, such as macrophages and dendritic cells, in responding to EVs further underscores their significance in immune communication. These cells rapidly react to the signals carried by EVs, leading to local and systemic immune effects. In cancer, EVs can facilitate chronic inflammation and immune evasion, while in autoimmune diseases, they may promote tissue damage and inflammation [3].

Moreover, the cargo of EVs is not limited to proteins; they also transport nucleic acids, including microRNAs, which can regulate gene expression in recipient cells, thereby influencing immune cell differentiation and function. The presence of specific miRNAs in EVs has been linked to various immune responses, including those involved in tumor immunity and inflammatory diseases [4].

In summary, extracellular vesicles serve as essential communicators in the immune system by transferring a complex array of proteins and nucleic acids. Their diverse cargo facilitates various immune processes, from activation and regulation to the modulation of responses in both health and disease contexts [9][10]. Understanding the protein composition and functional roles of EVs in immune communication can provide insights into potential therapeutic applications and diagnostic tools for immune-related disorders.

3.2 Lipid and RNA Content ​

Extracellular vesicles (EVs) play a crucial role in immune communication by facilitating the transfer of bioactive molecules between cells, thereby influencing immune responses. These vesicles, which include exosomes and microvesicles, are membrane-bound structures that contain a diverse array of cargo, including proteins, lipids, and nucleic acids such as RNA. The lipid and RNA content of EVs is particularly significant in modulating immune functions.

The lipid composition of EVs is essential for their biogenesis, cargo sorting, and the interactions they have with recipient cells. Lipids within EVs are involved in various signaling pathways and can modulate the functional effects on target cells. For instance, EVs can carry bioactive lipids that play important roles in the immune system, such as prostaglandins and leukotrienes, which are involved in inflammatory responses and immune regulation [11].

RNA content in EVs, particularly microRNAs (miRNAs), has been extensively studied for its role in immune communication. EVs can transport various types of RNA, including mRNA, miRNA, and long non-coding RNAs, which are protected within the lipid bilayer of the vesicles. This protection ensures their stability and allows for long-distance cellular interactions. The RNA molecules carried by EVs can influence gene expression in recipient cells, thereby modulating their immune responses. For example, exosomal miRNAs have been shown to be involved in the regulation of immune cell functions, affecting processes such as antigen presentation and the activation or suppression of immune cells [4].

Moreover, EVs are implicated in the communication between immune cells and tumor cells, where they can contribute to immune evasion and therapeutic resistance in cancer. Myeloid immune cells, such as dendritic cells and macrophages, respond rapidly to EVs, driving both local and systemic effects that can promote inflammation or tissue tolerance depending on the context [3].

In summary, extracellular vesicles serve as pivotal mediators of intercellular communication in the immune system, with their lipid and RNA content playing significant roles in modulating immune responses. The understanding of how EVs influence immune communication not only enhances our knowledge of immune regulation but also opens avenues for therapeutic applications targeting EVs in various diseases, including cancer and autoimmune disorders [1][2][6].

4 Role of Extracellular Vesicles in Immune Communication ​

4.1 EVs in Innate Immunity ​

Extracellular vesicles (EVs) play a critical role in immune communication, particularly in the context of innate immunity. These small membranous structures, which include exosomes and microvesicles, are secreted by various cell types and serve as important mediators of intercellular communication. Their involvement extends to both innate and adaptive immune responses, highlighting their significance in maintaining immune homeostasis and influencing the pathogenesis of immune-related disorders.

EVs are known to carry a diverse array of bioactive molecules, including proteins, lipids, and nucleic acids (such as RNA and DNA), which can modulate the function of recipient cells. For instance, they participate in immune cell activation, antigen presentation, and immunomodulation, thereby affecting the behavior of various immune cells, including neutrophils, monocytes, and macrophages. The immunomodulatory properties of EVs are particularly relevant as they can influence the differentiation and function of innate immune cells, impacting their response to pathogens and inflammation.

Research indicates that the composition and release of EVs can be altered in response to various pathological processes, including infections, cancer, and metabolic disorders. For example, in the context of mycobacterial infections, EVs have been shown to mediate antigen presentation and modulate immune responses, which underscores their role as critical effectors in immune regulation during infectious diseases [12]. Similarly, EVs derived from innate immune cells such as macrophages can promote tissue preservation during sterile injuries, such as myocardial infarction, and facilitate tissue resolution of inflammation [13].

Furthermore, EVs are also implicated in the communication between innate and adaptive immune systems. They can transfer signals that help orchestrate adaptive immune responses, thereby linking the rapid responses of innate immunity with the more specific and sustained responses of adaptive immunity [14]. This cross-talk is essential for a coordinated immune response and can also have therapeutic implications, as manipulating EVs could enhance vaccine efficacy or modulate undesirable immune responses in autoimmune diseases [6].

In summary, extracellular vesicles are pivotal players in immune communication, acting as vehicles for the transfer of information between cells, influencing both innate and adaptive immune responses, and providing potential therapeutic avenues for modulating immune functions in various disease contexts. Their ability to encapsulate and deliver a wide range of biologically active molecules makes them valuable in understanding immune regulation and developing new immunotherapeutic strategies.

4.2 EVs in Adaptive Immunity ​

Extracellular vesicles (EVs) play a pivotal role in immune communication, particularly in the context of adaptive immunity. These vesicles, which include exosomes and microvesicles, are small membranous structures secreted by nearly all cell types and have emerged as crucial mediators in intercellular communication. They significantly impact both innate and adaptive immune responses, highlighting their multifaceted involvement in immune regulation.

One of the primary functions of EVs in adaptive immunity is their capacity to facilitate antigen presentation. Professional antigen-presenting cells (APCs), such as dendritic cells, utilize EVs to deliver antigens to T cells, thereby initiating and maintaining adaptive immune responses. EVs can be formed through different mechanisms, including microvesicles that are directly pinched off from the plasma membrane or exosomes that are secreted by multivesicular endosomes. The specific membrane receptors on EVs guide them to target cells, allowing for the directional transfer of complex signaling cues that are essential for T cell activation and differentiation (Lindenbergh & Stoorvogel, 2018) [15].

Moreover, EVs carry a diverse cargo that includes proteins, lipids, RNA, and DNA, which can influence the gene expression of recipient cells. This cargo composition enables EVs to modulate immune cell activation, promote immune tolerance, or induce inflammation, depending on the context (Aloi et al., 2024) [1]. For instance, in cancer, EVs can contribute to the immunosuppressive microenvironment, leading to therapeutic resistance, while in autoimmune diseases, they may support inflammation and tissue destruction (Makhijani & McGaha, 2022) [3].

The communication facilitated by EVs extends beyond mere antigen presentation; they also play a critical role in the overall orchestration of adaptive immune responses. By influencing the behavior of T and B cells, EVs help to fine-tune the immune response, ensuring that it is appropriately activated in response to pathogens or altered in response to self-antigens in autoimmune conditions (Akbar et al., 2021) [13].

Furthermore, the complexity of EVs allows them to act as potential therapeutic agents. Their ability to encapsulate and deliver bioactive molecules makes them promising candidates for immunotherapies aimed at enhancing immune responses against tumors or modulating autoimmunity (Wang et al., 2025) [16].

In summary, extracellular vesicles are integral to immune communication, particularly in adaptive immunity, where they facilitate antigen presentation, modulate immune cell activity, and possess therapeutic potential. Understanding the mechanisms by which EVs influence immune responses is crucial for developing novel therapeutic strategies for various immunological disorders.

4.3 EVs in Immune Regulation and Tolerance ​

Extracellular vesicles (EVs), including exosomes and microvesicles, are pivotal mediators of intercellular communication within the immune system. These small membranous structures are secreted by nearly all cell types and have emerged as critical players in the regulation of immune responses, influencing both innate and adaptive immunity.

EVs carry a diverse array of bioactive molecules, such as proteins, lipids, nucleic acids (including mRNAs and microRNAs), and other cellular components derived from their parent cells. This cargo enables EVs to modulate the function of recipient cells through various mechanisms, including the transfer of genetic material that can alter gene expression and cellular behavior. For instance, exosomal microRNAs have been identified as significant regulators of immune cell communication, impacting processes such as macrophage activation and dendritic cell function, which are crucial for initiating and sustaining immune responses [4].

In the context of immune regulation, EVs play a multifaceted role. They are involved in the activation and modulation of immune cells, facilitating antigen presentation and influencing the overall immune tolerance mechanisms. For example, EVs derived from mesenchymal stromal cells (MSCs) exhibit potent immunomodulatory effects, which have been harnessed in clinical applications for treating immune-related disorders. The paracrine signaling mediated by MSC-derived EVs is believed to be a key mechanism underlying their therapeutic efficacy [17].

Furthermore, EVs have been implicated in the maintenance of immune homeostasis and the pathogenesis of various immune-related disorders. They can promote self-tolerance by transferring inhibitory signals to immune cells, thereby preventing excessive immune activation that could lead to autoimmune diseases [1]. In cancer, the interaction between tumor-derived EVs and immune cells can result in immune evasion, highlighting the dual role of EVs in both promoting and regulating immune responses [4].

Research indicates that EVs are involved in chronic inflammatory conditions, where they may contribute to the persistence of inflammation and tissue damage. Their capacity to carry pro-inflammatory cytokines and other mediators allows them to influence the local immune environment significantly [18]. Conversely, EVs can also exhibit anti-inflammatory properties, making them potential therapeutic targets for controlling inflammatory diseases [2].

In summary, extracellular vesicles are integral to immune communication, serving as vehicles for the transfer of regulatory signals and bioactive molecules that influence immune cell behavior and maintain immune balance. Their ability to modulate immune responses positions them as promising candidates for therapeutic interventions in a variety of immune-related diseases, including autoimmune disorders, cancer, and chronic inflammatory conditions. Understanding the precise mechanisms by which EVs operate will be crucial for developing novel diagnostic and therapeutic strategies targeting immune regulation [1][3][4].

5 Therapeutic Potential of Extracellular Vesicles ​

5.1 EVs as Biomarkers ​

Extracellular vesicles (EVs), which include exosomes and microvesicles, are small membranous structures secreted by nearly all cell types and have emerged as crucial mediators in intercellular communication, particularly within the immune system. They play significant roles in various physiological and pathological processes, notably in immune regulation, impacting both innate and adaptive immunity. EVs facilitate communication between cells by delivering a diverse array of bioactive molecules, including proteins, lipids, and nucleic acids, which can influence gene expression in target cells [1].

In the context of immune communication, EVs are involved in several critical functions. They participate in immune cell activation, antigen presentation, and immunomodulation, thereby contributing to the maintenance of immune homeostasis and the pathogenesis of immune-related disorders [1]. For instance, EVs derived from myeloid immune cells, such as dendritic cells and macrophages, can rapidly respond to various stimuli, driving local and systemic immune responses [3]. This is particularly evident in conditions such as cancer and autoimmune diseases, where EVs can modulate inflammation and tissue destruction [3].

The therapeutic potential of EVs is vast, particularly due to their ability to serve as natural carriers for biomolecules, making them promising candidates for drug delivery systems. Their capacity to encapsulate and transport therapeutic agents, including RNA and proteins, enhances their applicability in treating various diseases, including cancers and autoimmune disorders [4]. Furthermore, EVs can be engineered to improve their targeting capabilities, which could lead to more effective immunotherapies [4].

In addition to their therapeutic roles, EVs also hold significant promise as biomarkers for disease diagnosis and prognosis. The content of EVs reflects the physiological state of their parent cells, allowing them to serve as indicators of disease processes [2]. For example, changes in the cargo of EVs can provide insights into the immune status of patients with cancer or autoimmune diseases, aiding in the identification of disease progression and response to therapy [2].

Overall, the multifunctional roles of extracellular vesicles in immune communication, their potential as therapeutic agents, and their utility as biomarkers underscore their significance in both basic and clinical immunology. Continued research into the mechanisms by which EVs operate will likely unveil further applications and enhance our understanding of their impact on health and disease.

5.2 EVs in Immunotherapy and Vaccination ​

Extracellular vesicles (EVs) play a pivotal role in immune communication, acting as crucial mediators in intercellular signaling and immune regulation. These small membranous structures, which include exosomes and microvesicles, are secreted by nearly all cell types and are involved in transferring a variety of biomolecules, such as proteins, lipids, and nucleic acids, between cells. This capability allows EVs to influence immune responses and maintain homeostasis within the immune system.

One of the significant roles of EVs in immune communication is their involvement in antigen presentation. EVs can carry major histocompatibility complex (MHC) molecules and other antigenic components that facilitate the recognition of pathogens by immune cells. This process is crucial for the activation of T cells and the subsequent adaptive immune response [1]. Moreover, EVs have been shown to modulate the activity of various immune cells, including dendritic cells, macrophages, and T cells, by delivering bioactive molecules that can either stimulate or suppress immune functions [2].

In the context of immunotherapy, EVs are emerging as promising tools due to their natural ability to transport therapeutic agents. They can be engineered to carry specific antigens or immunomodulatory molecules, enhancing the efficacy of vaccines and other immunotherapeutic strategies. For instance, EVs derived from tumor cells can be utilized to create cancer vaccines that stimulate a robust immune response against tumor-associated antigens [19]. This approach not only enhances the targeting of immune responses but also minimizes the potential for systemic side effects commonly associated with traditional therapies.

Furthermore, the therapeutic potential of engineered EVs extends to their use as delivery vehicles for drugs and small molecules. Their unique properties, such as biocompatibility and low immunogenicity, make them ideal candidates for targeted drug delivery systems [20]. The ability of EVs to traverse biological barriers and deliver their cargo directly to target cells presents a significant advantage in developing new treatments for various diseases, including cancer and autoimmune disorders [16].

The modulation of immune responses by EVs also holds promise for addressing immunotherapeutic resistance, a significant challenge in cancer treatment. EVs can facilitate communication within the tumor microenvironment, influencing the behavior of immune cells and contributing to the evasion of immune surveillance by tumors [21]. Understanding the mechanisms by which EVs interact with the immune system is critical for developing effective immunotherapeutic strategies.

In summary, extracellular vesicles serve as essential mediators of immune communication, influencing both innate and adaptive immunity. Their ability to transfer bioactive molecules and modulate immune responses positions them as valuable tools in immunotherapy and vaccination, paving the way for innovative therapeutic applications in the treatment of various diseases. The ongoing research into the biology of EVs and their interactions with the immune system is likely to yield novel insights and strategies for enhancing immune responses against pathogens and tumors [22][23].

6 Future Directions and Challenges ​

6.1 Research Gaps ​

Extracellular vesicles (EVs) play a critical role in immune communication, serving as important mediators of intercellular signaling and influencing various immune responses. These lipid membrane-bound structures, which include exosomes and microvesicles, are secreted by nearly all cell types and carry a diverse range of bioactive molecules such as proteins, lipids, nucleic acids, and other signaling molecules. The involvement of EVs in immune communication is multifaceted, impacting both innate and adaptive immunity.

One significant function of EVs is their role in immune cell activation and modulation. They can transfer antigens and other signaling molecules to immune cells, facilitating antigen presentation and influencing the activation of T cells and B cells [1]. Furthermore, EVs can deliver microRNAs (miRNAs) that modulate gene expression in recipient cells, thereby shaping immune responses and contributing to immune homeostasis [4]. This ability to influence immune cell behavior highlights the potential of EVs as diagnostic and therapeutic tools in various immunological disorders, including autoimmune diseases, infectious diseases, and cancer [1][16].

Despite the promising implications of EVs in immune communication, there are several future directions and challenges that need to be addressed in this field. One of the primary challenges is the complexity and heterogeneity of EVs. Different subpopulations of EVs can have distinct compositions and biological effects, which complicates the understanding of their precise roles in immune modulation [24]. Future research should focus on characterizing these subpopulations to elucidate their specific functions and mechanisms of action.

Moreover, the biogenesis, secretion, and uptake mechanisms of EVs remain incompletely understood. A better understanding of these processes is essential for harnessing the therapeutic potential of EVs. For instance, identifying the pathways involved in EV production and release could lead to strategies that enhance or inhibit their function, depending on the therapeutic needs [16].

Research gaps also exist in the area of EVs' interactions with the tumor microenvironment and their role in immunotherapeutic resistance. As tumors release EVs that can modulate immune responses to facilitate their growth and metastasis, understanding these interactions could lead to novel therapeutic approaches to overcome resistance to immunotherapy [25]. Investigating how tumor-derived EVs affect immune cell function will be crucial for developing targeted strategies to enhance the efficacy of cancer immunotherapies [25].

In summary, while extracellular vesicles are integral to immune communication and hold significant promise for therapeutic applications, ongoing research is necessary to address the challenges of their complexity, biogenesis, and interaction with the immune system, particularly in the context of cancer and other diseases. Understanding these aspects will pave the way for innovative strategies to leverage EVs in clinical settings.

6.2 Technical Challenges in EV Study ​

Extracellular vesicles (EVs) play a significant role in immune communication by serving as vehicles for the transfer of bioactive molecules, including proteins, lipids, and nucleic acids, between cells. These small membranous structures, which include exosomes and microvesicles, are secreted by nearly all cell types and have emerged as crucial mediators in intercellular communication, particularly in the context of immunity. EVs are involved in various immune processes, such as immune cell activation, antigen presentation, and immunomodulation, thereby influencing both innate and adaptive immune responses [1].

The multifaceted roles of EVs in immune communication include the delivery of molecular signals that can activate or suppress immune cells, modulate gene expression in recipient cells, and maintain immune homeostasis. For instance, myeloid immune cells, including dendritic cells and macrophages, respond rapidly to EVs, which can drive local and systemic immune effects. In the context of cancer and autoimmune diseases, EVs have been shown to contribute to chronic inflammation and tissue destruction [3].

Moreover, EVs facilitate the communication between tumor cells and the immune system, playing a critical role in tumor progression and immune evasion. They can transfer oncogenic signals and immune-modulatory molecules, which can alter the immune landscape and promote tumor growth [26].

Despite the promising roles of EVs in immune communication, several technical challenges hinder the study and application of EVs in therapeutic contexts. One of the primary challenges is the isolation and characterization of EVs, which is complicated by their heterogeneity and the presence of contaminants from other cellular debris. Different EV subtypes may require specific isolation techniques to ensure purity and functionality [7]. Additionally, the standardization of methodologies for EV analysis remains a significant hurdle, as variations in isolation protocols can lead to inconsistent results across studies [2].

Another challenge is the need for a deeper understanding of the molecular mechanisms underlying EV biogenesis, cargo selection, and the functional outcomes of EV-mediated communication. This includes elucidating how specific cargo molecules within EVs influence recipient cell behavior and the subsequent immune responses [5]. Furthermore, the dynamic nature of EVs in different biological contexts necessitates the development of more sophisticated experimental models to accurately reflect their roles in vivo [8].

Future research should focus on addressing these technical challenges to harness the full potential of EVs in immunotherapy and diagnostics. By improving isolation techniques, standardizing analytical methods, and exploring the molecular underpinnings of EV function, it may be possible to translate EV-based therapies into clinical applications more effectively. Understanding the intricate interplay between EVs and the immune system could lead to novel therapeutic targets and diagnostic tools for various immune-related disorders [4].

7 Conclusion ​

Extracellular vesicles (EVs) are pivotal players in immune communication, influencing both innate and adaptive immune responses. They facilitate intercellular signaling by transferring a diverse array of bioactive molecules, including proteins, lipids, and nucleic acids, which can modulate the behavior of recipient cells. The complexity and heterogeneity of EVs pose challenges in understanding their precise roles in immune regulation. Current research highlights their dual functions in promoting immune activation and tolerance, making them significant in the pathogenesis of various immune-related disorders, including cancer and autoimmune diseases. Future research should focus on characterizing different EV subpopulations, elucidating their biogenesis and uptake mechanisms, and exploring their interactions within the tumor microenvironment. Addressing these gaps will be crucial for harnessing the therapeutic potential of EVs and developing novel strategies for immunotherapy and diagnostics. By leveraging the multifaceted roles of EVs, we can advance our understanding of immune regulation and improve clinical outcomes for patients with immune-related conditions.

References ​

  • [1] Noemi Aloi;Gaspare Drago;Silvia Ruggieri;Fabio Cibella;Paolo Colombo;Valeria Longo. Extracellular Vesicles and Immunity: At the Crossroads of Cell Communication.. International journal of molecular sciences(IF=4.9). 2024. PMID:38256278. DOI: 10.3390/ijms25021205.
  • [2] Paul D Robbins;Adrian E Morelli. Regulation of immune responses by extracellular vesicles.. Nature reviews. Immunology(IF=60.9). 2014. PMID:24566916. DOI: 10.1038/nri3622.
  • [3] Priya Makhijani;Tracy L McGaha. Myeloid Responses to Extracellular Vesicles in Health and Disease.. Frontiers in immunology(IF=5.9). 2022. PMID:35320943. DOI: 10.3389/fimmu.2022.818538.
  • [4] Kaylyn M Bauer;June L Round;Ryan M O'Connell. No small matter: emerging roles for exosomal miRNAs in the immune system.. The FEBS journal(IF=4.2). 2022. PMID:34087046. DOI: 10.1111/febs.16052.
  • [5] Arash Latifkar;Richard A Cerione;Marc A Antonyak. Probing the mechanisms of extracellular vesicle biogenesis and function in cancer.. Biochemical Society transactions(IF=4.3). 2018. PMID:30301841. DOI: 10.1042/BST20180523.
  • [6] Howida M Nail;Chien-Chih Chiu;Chung-Hang Leung;Mahmoud M M Ahmed;Hui-Min David Wang. Exosomal miRNA-mediated intercellular communications and immunomodulatory effects in tumor microenvironments.. Journal of biomedical science(IF=12.1). 2023. PMID:37605155. DOI: 10.1186/s12929-023-00964-w.
  • [7] Rahul Sanwlani;Lahiru Gangoda. Role of Extracellular Vesicles in Cell Death and Inflammation.. Cells(IF=5.2). 2021. PMID:34685643. DOI: 10.3390/cells10102663.
  • [8] José Manuel Rodrigo-Muñoz;Marta Gil-Martínez;Sara Naharro-González;Victoria Del Pozo. Eosinophil-derived extracellular vesicles: isolation and classification techniques and implications for disease pathophysiology.. Journal of leukocyte biology(IF=3.1). 2024. PMID:38836652. DOI: 10.1093/jleuko/qiae133.
  • [9] Clotilde Théry;Matias Ostrowski;Elodie Segura. Membrane vesicles as conveyors of immune responses.. Nature reviews. Immunology(IF=60.9). 2009. PMID:19498381. DOI: 10.1038/nri2567.
  • [10] Nathalie Chaput;Clotilde Théry. Exosomes: immune properties and potential clinical implementations.. Seminars in immunopathology(IF=9.2). 2011. PMID:21174094. DOI: 10.1007/s00281-010-0233-9.
  • [11] Krizia Sagini;Eva Costanzi;Carla Emiliani;Sandra Buratta;Lorena Urbanelli. Extracellular Vesicles as Conveyors of Membrane-Derived Bioactive Lipids in Immune System.. International journal of molecular sciences(IF=4.9). 2018. PMID:29670015. DOI: 10.3390/ijms19041227.
  • [12] Jianjun Wang;Yang Wang;Lijun Tang;Rodolfo C Garcia. Extracellular Vesicles in Mycobacterial Infections: Their Potential as Molecule Transfer Vectors.. Frontiers in immunology(IF=5.9). 2019. PMID:31474995. DOI: 10.3389/fimmu.2019.01929.
  • [13] Naveed Akbar;Daan Paget;Robin P Choudhury. Extracellular Vesicles in Innate Immune Cell Programming.. Biomedicines(IF=3.9). 2021. PMID:34201592. DOI: 10.3390/biomedicines9070713.
  • [14] Tom Groot Kormelink;Sanne Mol;Esther C de Jong;Marca H M Wauben. The role of extracellular vesicles when innate meets adaptive.. Seminars in immunopathology(IF=9.2). 2018. PMID:29616308. DOI: 10.1007/s00281-018-0681-1.
  • [15] Marthe F S Lindenbergh;Willem Stoorvogel. Antigen Presentation by Extracellular Vesicles from Professional Antigen-Presenting Cells.. Annual review of immunology(IF=33.3). 2018. PMID:29400984. DOI: 10.1146/annurev-immunol-041015-055700.
  • [16] Shuai Wang;Zerui Wang;Min Liu;Xiyang Sun. Role of extracellular vesicles in cancer: implications in immunotherapeutic resistance.. Frontiers in immunology(IF=5.9). 2025. PMID:40475777. DOI: 10.3389/fimmu.2025.1581635.
  • [17] Jorge Diego Martin-Rufino;Natalia Espinosa-Lara;Lika Osugui;Fermin Sanchez-Guijo. Targeting the Immune System With Mesenchymal Stromal Cell-Derived Extracellular Vesicles: What Is the Cargo's Mechanism of Action?. Frontiers in bioengineering and biotechnology(IF=4.8). 2019. PMID:31781552. DOI: 10.3389/fbioe.2019.00308.
  • [18] Diana Karpman;Ashmita Tontanahal. Extracellular vesicles in renal inflammatory and infectious diseases.. Free radical biology & medicine(IF=8.2). 2021. PMID:33933600. DOI: 10.1016/j.freeradbiomed.2021.04.032.
  • [19] Carla Giacobino;Marta Canta;Cristina Fornaguera;Salvador Borrós;Valentina Cauda. Extracellular Vesicles and Their Current Role in Cancer Immunotherapy.. Cancers(IF=4.4). 2021. PMID:34068657. DOI: 10.3390/cancers13092280.
  • [20] Kyle I Mentkowski;Jonathan D Snitzer;Sarah Rusnak;Jennifer K Lang. Therapeutic Potential of Engineered Extracellular Vesicles.. The AAPS journal(IF=3.7). 2018. PMID:29546642. DOI: 10.1208/s12248-018-0211-z.
  • [21] Aleli Salazar;Víctor Chavarria;Itamar Flores;Samanta Ruiz;Verónica Pérez de la Cruz;Francisco Javier Sánchez-García;Benjamin Pineda. Abscopal Effect, Extracellular Vesicles and Their Immunotherapeutic Potential in Cancer Treatment.. Molecules (Basel, Switzerland)(IF=4.6). 2023. PMID:37175226. DOI: 10.3390/molecules28093816.
  • [22] João Henrique Campos;Rodrigo Pedro Soares;Kleber Ribeiro;André Cronemberger Andrade;Wagner Luiz Batista;Ana Claudia Torrecilhas. Extracellular Vesicles: Role in Inflammatory Responses and Potential Uses in Vaccination in Cancer and Infectious Diseases.. Journal of immunology research(IF=3.6). 2015. PMID:26380326. DOI: 10.1155/2015/832057.
  • [23] Elham Hosseini-Beheshti;Georges Emile Raymond Grau. Extracellular vesicles as mediators of immunopathology in infectious diseases.. Immunology and cell biology(IF=3.0). 2018. PMID:29577413. DOI: 10.1111/imcb.12044.
  • [24] Kevin Ho Wai Yim;Ala'a Al Hrout;Simone Borgoni;Richard Chahwan. Extracellular Vesicles Orchestrate Immune and Tumor Interaction Networks.. Cancers(IF=4.4). 2020. PMID:33317058. DOI: 10.3390/cancers12123696.
  • [25] Qi Li;Suna Cai;Mengjiao Li;Kab Ibrahim Salma;Xiaojie Zhou;Feiyu Han;Jinzhao Chen;Ting Huyan. Tumor-Derived Extracellular Vesicles: Their Role in Immune Cells and Immunotherapy.. International journal of nanomedicine(IF=6.5). 2021. PMID:34408415. DOI: 10.2147/IJN.S313912.
  • [26] Sonam Mittal;Prachi Gupta;Pradeep Chaluvally-Raghavan;Sunila Pradeep. Emerging Role of Extracellular Vesicles in Immune Regulation and Cancer Progression.. Cancers(IF=4.4). 2020. PMID:33260606. DOI: 10.3390/cancers12123563.

MaltSci Intelligent Research Services ​

Search for more papers on MaltSci.com ​

extracellular vesicles · immune communication · antigen presentation · immune regulation · therapeutic potential

© 2025 MaltSci